Events

ESMO 2021: EORTC-ETOP NIVOTHYM Study

By ONA Editor September 23, 2021 No Comments

Highlights on nivolumab in pretreated thymoma & thymic carcinoma: EORTC-ETOP NIVOTHYM study

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

About Author

Related Posts

AACR 2026: Novel approach prevents cancer progression, spares surgery for majority of patients with precancerous oral lesions

FDA approves nivolumab with chemotherapy for previously untreated Hodgkin lymphoma

Combination immunotherapy shows improved efficacy and survival rates in rare cancer study

Leave A Reply Cancel Reply